Schatz & Nobel Announce Lawsuit Against Cell Therapeutics

The law firm of Schatz & Nobel, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Western District of Washington on behalf of all persons who purchased the publicly traded securities of Cell Therapeutics between June 7, 2004, and March 4, 2005, inclusive.

Yahoo News (http://biz.yahoo.com/prnews/050311/phf034_1.html)